{"organizations": [], "uuid": "078369224c98de73ad70922dd85c71b95059f1a9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180214.html", "section_title": "Archive News &amp; Video for Wednesday, 14 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-ortho-dermatologics-says-us-fda-fi/brief-ortho-dermatologics-says-u-s-fda-filing-acceptance-for-jemdel-plaque-psoriasis-treatment-idUSFWN1Q413T", "country": "US", "domain_rank": 408, "title": "BRIEF-Ortho Dermatologics Says U.S. FDA Filing Acceptance For Jemdel Plaque Psoriasis Treatment", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.029, "site_type": "news", "published": "2018-02-14T20:06:00.000+02:00", "replies_count": 0, "uuid": "078369224c98de73ad70922dd85c71b95059f1a9"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-ortho-dermatologics-says-us-fda-fi/brief-ortho-dermatologics-says-u-s-fda-filing-acceptance-for-jemdel-plaque-psoriasis-treatment-idUSFWN1Q413T", "ord_in_thread": 0, "title": "BRIEF-Ortho Dermatologics Says U.S. FDA Filing Acceptance For Jemdel Plaque Psoriasis Treatment", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "u.s. fda filing acceptance for jemdel plaque psoriasis treatment feb", "sentiment": "negative"}, {"name": "reuters) - valeant pharmaceuticals international inc", "sentiment": "neutral"}, {"name": "fda", "sentiment": "none"}, {"name": "pdufa", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Valeant Pharmaceuticals International Inc :\n* ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR JEMDEL™ PLAQUE PSORIASIS TREATMENT\n* ‍ORTHO DERMATOLOGICS - FDA ACCEPTED NEW DRUG APPLICATION FOR JEMDEL LOTION WITH A PDUFA ACTION DATE OF OCT 5, 2018​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T20:06:00.000+02:00", "crawled": "2018-02-15T20:40:45.035+02:00", "highlightTitle": ""}